| Diane M Eodice, DO | |
|
820 N Montana Ave, Helena, MT 59601-3856 | |
| (406) 443-7733 | |
| (406) 443-8292 |
| Full Name | Diane M Eodice |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 820 N Montana Ave, Helena, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023098696 | NPI | - | NPPES |
| 0092667 | Medicaid | MT | |
| 0098935 | Other | MT | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9893 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diane M Eodice, DO 820 North Montana Avenue, Helena, MT 59601-4926 Ph: (406) 443-7733 | Diane M Eodice, DO 820 N Montana Ave, Helena, MT 59601-3856 Ph: (406) 443-7733 |
News Archive
Among the treatments for obstructive sleep apnea, the effectiveness of a nighttime-breathing machine called a "CPAP" was backed by the strongest evidence, and a mouthpiece worn at night was also shown to be effective, according to a new report funded by HHS' Agency for Healthcare Research and Quality.
Follow-up data from the landmark SPRINT study of the effect of high blood pressure on cardiovascular disease have confirmed that aggressive blood pressure management - lowering systolic blood pressure to less than 120 mm Hg - dramatically reduces the risk of heart disease, stroke, and death from these diseases, as well as death from all causes, compared to lowering systolic blood pressure to less than 140 mm Hg.
Teva Pharmaceutical Industries Ltd. announced today that it has entered into two definitive agreements with AstraZeneca to settle patent litigation regarding Teva's U.S. generic versions of AstraZeneca's Prilosec® (omeprazole) and Nexium® (esomeprazole), including all claims for patent infringement and damages.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
President Barack Obama is so confident of the constitutionality of his signature Affordable Care Act -; and so happy to cast Mitt Romney as his human shield against its Republican critics-; that he did little to stop the Supreme Court from fast-tracking a ruling on the law now likely to come in the middle of the 2012 campaign.
› Verified 1 days ago
John J Cassani, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2550 E Broadway St, Helena, MT 59601 Phone: 406-457-4180 | |
Dr. William Christopher Snider, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1930 9th Ave, Helena, MT 59601 Phone: 406-457-0000 Fax: 406-500-2128 | |
Brian W Abbott, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3150 N Montana Ave Ste A, Helena, MT 59602 Phone: 406-422-5817 Fax: 406-422-5928 | |
Holly Lee Hoffman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2619 Colonial Dr, Suite A, Helena, MT 59601 Phone: 406-442-1231 Fax: 406-442-6857 | |
Andrew P Gilbert, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2550 E Broadway St, Helena, MT 59601 Phone: 406-457-4180 | |
Dr. Heather Mcree, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1930 9th Ave, Helena, MT 59601 Phone: 406-457-0000 Fax: 406-500-2128 |